Conference Coverage

Single dose bacterial vaginosis treatment performs well in phase III trial

Publish date: August 30, 2016

 

AT IDSOG

References

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Pages

Recommended Reading

Should risk-reducing gynecologic surgery for BRCA mutation carriers include hysterectomy?
MDedge ObGyn
Was the pregnancy ectopic or intrauterine?
MDedge ObGyn
Product Update: AVYCAZ, Electro Lube, Methergine Oral Tablets, ChartLogic
MDedge ObGyn
In which clinical situations can the use of the 52-mg levonorgestrel-releasing IUD (Mirena) and the TCu380A copper-IUD (ParaGard) be extended?
MDedge ObGyn
2016 Update on female sexual dysfunction
MDedge ObGyn
Symptoms are a poor surrogate for detecting PID
MDedge ObGyn
Power morcellation dropped, abdominal hysterectomy increased after FDA warning
MDedge ObGyn
Integrated PrEP and ART prevents HIV transmission in couples
MDedge ObGyn
Sterilization rates decline for women despite coverage
MDedge ObGyn
HIV infection linked with death from cervical cancer
MDedge ObGyn